Skip to main content
Download PDF
Download ePub

Attitudes, awareness, and perceptions of general public and pharmacists toward the extended community pharmacy services and drive-thru pharmacy services: a systematic review

Journal of Pharmaceutical Policy and Practice volume 16, Article number: 37 (2023) Cite this article

Abstract

Background

Several extended and newly added pharmacy services were evaluated in different countries. This review aims to provide a summary of studies on attitudes, awareness, or perceptions toward various extended and drive-thru pharmacy services at community settings among pharmacists and the general public.

Methods

To find qualitative and descriptive quantitative studies, that reported on the attitudes, awareness, or perceptions of the general public and pharmacists toward the practice of any extended community pharmacy service and drive-thru pharmacy services in a community setting and conducted from March 2012 to March 2022. Researchers used databases such as Embase, Medline PubMed, Scopus, Web of Science, and Science Direct. The reviewers extracted data independently using the PRISMA checklist.

Results

There were 55 studies found according to the inclusion criteria. Various extended pharmacy services (EPS) and drive-thru pharmacy services were noted in the community setting. Pharmaceutical care services and healthcare promotion services were the noticeable performed extended services. There were positive perceptions and attitudes toward extended and drive-thru pharmacy services among pharmacists and the public. However, some factors, such as lack of time and shortage of staff, affect the practice of those services.

Conclusion

Understanding the major concerns toward the provision of extended and drive-thru community pharmacy services and improving pharmacists’ skills through more training programs to provide such services efficiently. In the future, more reviews for EPS practice barriers are recommended to faceup all concerns and find standardized guidelines by stakeholders and organizations for efficient EPS practices.

Introduction

Pharmacists are considered accessible healthcare providers without the need for appointments to get consultations or counseling [1]. Pharmaceutical care can be applied in all settings, i.e., community, hospital, clinic, and others [2]. Pharmaceutical care at community pharmacy settings added a wide range of services, ranging from providing concise counseling to detailed counseling and other value-added services which are known to be extended pharmacy services [3].

Community pharmacists are widely considered multidisciplinary healthcare providers, and their roles moved to be more patients’ oriented than focusing on products only [4, 5]. In the United States (U.S.), a community pharmacist is considered as an accessible primary healthcare provider [6]. A community pharmacist provides efficient health services which reduce the burden on primary health institutions, for example, administrating vaccinations during outbreaks such as during the time of the H1N1 pandemic in 2009 [7, 8] resulted in an elevation of the number of the pandemic vaccine doses administered and reduction of the time for getting 80% vaccination coverage [8]. Community pharmacists are vital in providing primary healthcare services in Canada, as evidenced by the value of their pharmaceutical care services in several pharmacy practice projects [9]. Moreover, community pharmacy is considered as an ideal setting to provide healthcare services for the public compared to other primary healthcare settings because it is accessible for both urban and rural areas with relatively long opening hours [10,11,12].

Extended pharmacy services (EPS) are related to the services that are provided at pharmacies other than traditional services (ex. dispensing the prescribed or non-prescribed medications and giving counseling or instructions about dispensed medications). EPS include identifying medication-related problems by doing comprehensive medication reviews, providing some monitoring for diseases such as measuring blood pressure reading or blood glucose level, and contacting the primary healthcare team [3, 13]. Medication-related problems can be identified too by getting involved in disease management by doing a series of services such as detailed patient education about medications or health-related diseases [3, 13]. In addition to the EPS, there are newly added services at pharmacies such as drive-thru service or drive-through service [14].

The first drive-thru pharmacy service was initiated by Walgreens pharmacy in the United States in the 1990s and nowadays it is spread to many countries around the globe [14], such as the United Kingdom [15], Australia [16], Croatia [17], Taiwan [18], Malaysia [19], Jordan [20], Saudi Arabia [21], and Qatar [22]. Drive-thru services were established either at hospital or community pharmacy settings or both, to reduce waiting time in the pharmacies, to improve the availability and provision of healthcare services for the targeted population, and recently to improve safety during COVID-19 [23].

Quality assessment of pharmacy services can be judged by regulatory agencies, consumers, and drug-service providers [24]. Patients’ perceptions toward healthcare service is an indicator of successful implementation of service that can be evaluated by patients’ perceptions toward that service [25, 26]. To determine the quality level of pharmacy service, it is very important to consider the pharmacists’ perspectives toward provided services [27] and compare consumers’ perceptions and expectations with pharmacists’ perceptions and willingness toward healthcare services [28].

Several implemented extended pharmacy services and drive-thru services at the community setting have been evaluated in different countries by exploring pharmacists’ or public’s perceptions toward those services. This review aims to summarize attitudes, awareness, or perceptions toward various extended including drive-thru pharmacy services at community settings among pharmacists and the public, to figure out the extent of the practice of such services, and the factors that affect its provision, so standardized guidelines for efficient practice can be found by stakeholders.

Methods

This systematic review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) statement, and it was registered with PROSPERO on April 13, 2022 [Registration number: CRD42022314516].

Eligibility criteria

Table 1 summarizes the inclusion and exclusion criteria. Observational descriptive quantitative and qualitative studies conducted from March 2012 to March 2022 that reported the attitudes, awareness, or perceptions of the general public and pharmacists toward the practice of any extended community pharmacy service and drive-thru pharmacy services in a community setting and were published in peer-reviewed journals in the English language were included.

Table 1 Inclusion criteria of studies in the systematic review
Full size table

A simple definition of attitudes is a mindset or tendency of acting toward something in a certain way according to personal experiences [29]. However, the definition of perceptions is the process by which individuals organize and interpret their impressions toward any kind of information in the environment [29]. Moreover, the definition of awareness is the knowledge that something exists [30].

Exclusion criteria were based on studies that reported attitudes, awareness, or perceptions related to any extended pharmacy service in a hospital context, in grocery shops, or in only certain chain pharmacy or outpatient pharmacy or pharmacy that provided certain EPS promoted by drug companies or any pharmacy provided certain workshops or training regarding EPS and assessed the awareness or knowledge after training. In addition, studies not published in English, reports, commentaries, preliminary studies, pilot studies, editorials, book chapters, systematic reviews, conference abstracts, or meta-analysis were not considered.

Search strategy

An extensive literature search was conducted to find studies on the attitudes, awareness, or perceptions toward the practice of any extended community pharmacy service and drive-thru pharmacy service among the public or community pharmacists in the following databases: Google Scholar, Embase, Medline PubMed, Scopus, Web of Science, and Science Direct, from March 2012 to March 2022 using keywords and Medical Subject Headings (MeSH) terms. The eligible studies were identified by using the following search keywords: extended community pharmacy services, drive-thru pharmacy, customers, public, consumers, pharmacists, attitude, awareness, and perceptions. Populations were not confined to a single country or location. The search keywords were found in either the title or abstract. These keywords were used in connection with one another using Boolean operators ("OR", "AND") and truncation. A supplemental search was done by hand-searching of bibliography lists from all included papers and receiving email alerts for any newly published relevant papers from pre-specified databases to find other papers that were not identified through the electronic search.

Study selection

The primary reviewer (BFA) imported the search results from all databases into Mendeley reference software, where duplicates were removed. Study selection was done independently by two reviewers (BFA and LA). Any disagreement or uncertainty regarding the inclusion or the exclusion of the studies during the screening process was resolved by discussion between the reviewers, or consultation with a third reviewer (FM). The first phase was the title and abstract screening conducted by two reviewers (BFA and FM) then the selected studies were verified by the primary reviewer (BFA). In the second phase, two reviewers did full-text screening independently (BFA and LA). The final list of studies was developed as a consensus of all reviewers to determine the reasons for exclusion.

Data extraction

Two reviewers (BFA and FM) completed data extraction independently using a standardized Excel spreadsheet (Microsoft Corp, Redmond, Washington). Any disagreement was resolved by discussion between the two reviewers, or by consultation with a third reviewer (LA). Data extraction for descriptive cross-sectional studies included the name of the first author, year of publication, study country, study design, study objectives, name of the extended community pharmacy service, study participants, inclusion and exclusion criteria, sample size, method of data collection, data analysis, and a summary of major conclusions. Data extraction for qualitative studies or mixed-method studies included the name of the first author, year of publication, study country, study design, study objectives, name of the extended community pharmacy service, study participants, inclusion and exclusion criteria, sample size, method of data collection, data analysis, major themes, and a summary of major conclusions.

Quality assessment

Two reviewers (BFA and FM) independently assessed the quality of the included studies (n = 55), during the data extraction phase. It was assessed based on the type of the studies, for descriptive cross-sectional studies, the National Institute of Health (NIH) quality assessment tool for observational cohort and cross-sectional studies was used, which includes 9 statements with the following options: yes, no, cannot determine, not applicable, and not reported [31]. Joanna Briggs Institute (JBI) critical appraisal checklist for qualitative studies was used for qualitative studies, including 10 statements with yes, no, unclear, and not applicable options [32]. The Mixed Methods Appraisal Tool (MMAT) was used for mixed methods studies, which includes 5 statements with yes, no, and cannot tell [33].

Data synthesis

A Synthesis Without Meta-Analysis (SWiM) was conducted on the included studies, due to the heterogeneity of the studies [34]. Studies were grouped based on the assessed extended pharmacy service and based on the targeted population. Extended community pharmacy services among pharmacists were categorized into 5 categories: (1) pharmaceutical care, (2) professional and public health activities, (3) extended pharmacy services for special groups of population, (4) health promotion activities, (5) drive-thru pharmacy services. The studies that assessed pharmaceutical care were grouped under pharmaceutical care category. The studies that assessed any of professional or public health activities such as medication reconciliation service, professional interactions between community pharmacists and general practitioners, public health activities such as providing education about the cessation of smoking, good oral hygiene, and measurements of blood pressure and blood glucose level, and inter/intra-professional activities were grouped under professional and public health activities category. The studies that discussed certain extended pharmacy service for special group of population, such as community Pharmacy Anticoagulation Management Service, pharmaceutical care for patients with dementia, pharmaceutical services for the elderly, pharmaceutical care for osteoporosis, and others were grouped under extended pharmacy services for special group of population category. Studies that assessed health promotion activities such as health-promotion and health education activities, counselling of diabetes, asthma, oral contraceptives, smoking cessation, nutrition and physical activity, oral health, and vaccinations were grouped under the health promotion activities category. Studies that assessed drive-thru community pharmacy service were categorized under drive-thru pharmacy services. Extended community pharmacy services among public or consumers were categorized into 2 categories: (1) extended pharmacy services, (2) drive-thru pharmacy services.

Results

Study characteristics

After removing duplicates, a final search strategy from all databases resulted in 4446 total studies. For the full-text screening phase, 318 studies were included. After the full-text screening, 55 studies (49 cross-sectional, 3 qualitative, and 3 mixed-method studies) were accepted for extraction based on the inclusion and exclusion criteria for this review (Fig. 1). A total of 4391 studies were excluded from the study selection process. The extracted data are summarized in Additional file 1.

Fig. 1
figure 1

PRISMA flow diagram of the selection process for the systematic review studies

Full size image

Of the total 55 included studies, there were 49 descriptive cross-sectional studies, 3 qualitative studies, and 3 mixed-method studies. The included studies were conducted in 26 different countries where five were conducted in Europe (Ireland, United Kingdom (UK), Bulgaria), three in North America (Jamaica, Canada), three in Oceania (Australia, New Zealand), 39 in Asia (Malaysia, Jordan, Yemen, Palestine, Qatar, United Arab Emirates (UAE), Lebanon, China, Iran, Iraq, Egypt, Turkey, Nepal, and Pakistan), and five in Africa (Nigeria, Ghana, South Africa). Malaysia was the most prominent for cross-sectional studies (n = 13) and qualitative studies were conducted in Pakistan, the United Kingdom, and Canada. While the mixed-method studies were conducted in New Zealand (n = 2) and Australia. Most studies investigated pharmacists’ perceptions (n = 52), with only three studies investigated general population perceptions (n = 3). Most of the cross-sectional studies used self-administered questionnaires for data collection, while qualitative studies used the semi-structured interviews (n = 2) and one used focused group interviews. For the mixed methods studies surveys and interviews have been used.

The included studies are presented in Additional file 1, which shows pharmacists’ awareness, perceptions, or attitudes toward various extended pharmacy services and drive-thru service at community setting including: extended role services [35], pharmaceutical care services [36,37,38,39,40,41,42,43,44], over-the-counter pharmaceutical services [45, 46], health promotion and health education [47], public health activities [48, 49], value-added services [50], minor aliment services [51], medication reconciliation [52], professional services [53, 54], services for people with mental disorders [55,56,57], lifestyle assistance services for people with cardiovascular diseases [58], anticoagulation management services [59], services for geriatrics [60], osteoporosis assessment screening [61], back pain management services [62], Human Papillomavirus (HPV) Vaccination Services [63], emergency contraception services [64], clinical services [65], intermediate care services [66, 67], interactions with general practitioners [68], oral health services [69, 70], dermatologic care services [71, 72], travel medicine services [73], smoking cessation counselling [74, 75], weight management services [76], nutrition counselling [77], cancer health promotion [78], breast cancer health promotion [79,80,81,82,83,84], bowel and breast cancer screening [85], and drive-thru pharmacy services [20]. Studies that showed public’s awareness or perceptions or attitudes toward various extended pharmacy services and drive-thru services at community settings were; weight management services [86], current pharmacists’ role [87], and drive-thru services [88].

Of the 49 included descriptive cross-sectional studies, 19 studies reported the attitudes, 13 studies reported the attitudes and perceptions, 8 studies reported the perceptions, 4 studies reported the attitudes, awareness, and perceptions, 3 studies reported the awareness and perceptions, and 2 studies reported the awareness toward EPS. Of the 3 included qualitative studies, 2 studies reported the awareness and attitudes, and one study reported the attitudes and perceptions toward EPS. Of the 3 included mixed-method studies, 2 studies reported the perceptions, and one study reported the attitudes and perceptions toward EPS.

Table 2 shows details of country which indicated extended services and drive-thru service at community pharmacy setting according to the inclusion criteria of this review. The most noticed service was the pharmaceutical care services (n = 9), followed by breast cancer health promotion services (n = 6). Pharmacists in Malaysia had represented various extended services at community setting (n = 13), followed by Jordan (n = 5). Drive-thru service at a community pharmacy setting was performed in Jordan (n = 2).

Table 2 Summary of extended services and drive-thru service at community pharmacy setting according to the inclusion criteria of this review
Full size table

Methodological quality

Generally, most of the studies got good quality using the assessment tools according to the study design. For descriptive cross-sectional studies, the majority of studies achieved yes for the 9 statements of the National Institute of Health (NIH) quality assessment tool for observational cohort and cross-sectional studies. For qualitative studies, all three studies achieved yes for the 10 statements of the Joanna Briggs Institute (JBI) critical appraisal checklist for qualitative studies. Similarly, for mixed-method studies, all three studies achieved yes for the 5 statements of the Mixed Methods Appraisal Tool (MMAT) (see Additional file 2). These assessment tools used only the yes, no scoring method. For ease of doing the quality assessment for the studies, the reviewers converted yes, no, not reported, not available, and cannot determine scores into numerical scores. We marked 1 for each yes, and 0 for each no or not reported or cannot determine or not available. For descriptive cross-sectional studies, the grading was decided based on the total score out of 9 for each study: 0–3 (poor), 4–6 (fair), and 7–9 (good). For qualitative studies, the grading was decided based on the total score out of 10 for each study: 0–3 (poor), 4–6 (fair), and 7–10 (good). For mixed-method studies, the grading was decided based on the total score out of 5 for each study: 0–1 (poor), 2–3 (fair), and 4–5 (good). Among descriptive cross-sectional studies, 48 studies out of 49 achieved good quality scoring and only one achieved fair quality scoring. Qualitative and mixed-method studies all achieved good quality scoring (see Additional file 3). No studies were excluded based on the methodological quality assessment, as only poor quality studies were planned to be excluded from data synthesis. This approach of excluding poor quality studies from data synthesis was reported in previous systematic reviews [89,90,91]. Two researchers scored each on the included studies independently. Any disagreements were resolved by discussion.

Attitudes, awareness, and perceptions of community pharmacists toward extended community pharmacy services

Pharmaceutical care

In Nigeria (2014), 95% of community pharmacists perceived that pharmaceutical care is a valuable service that may improve patients’ health and raise consumers’ confidence in the pharmacy profession which will enhance pharmacy practice [40]. In 2019, positive attitudes toward pharmaceutical care (51.2%) were showed among Nigerian community pharmacists’, however, their practice was poor because of a shortage of staff, poor collaboration with other healthcare providers; lack of pharmaceutical care skills, and the time-consuming of pharmaceutical care provision [36]. Compared to Nigeria, in Pakistan (2017), there was poor awareness with positive attitudes toward extended pharmacy services and pharmaceutical care among community pharmacists in Lahore due to a shortage of manpower, training programs, and others [35], and in 2020, they started providing pharmaceutical care (38.9%) to improve consumers’ health outcomes [43]. In Malaysia (2021), community pharmacists in Kuala Lumpur had positive attitudes toward the practice of pharmaceutical care (93.7%) [44]. In Jamaica (2021), community pharmacists showed positive attitudes toward pharmaceutical care as well (> 80%) and the shortage of resources is the main cause of not practicing pharmaceutical care [41]. In Poland (2021), community pharmacists perceived that pharmaceutical care practice is very important but lack of time is the main reason for not providing it all the times [38]. Same practice of pharmaceutical care was documented in China (2016) by community pharmacists [37]. In Iran (2015), pharmacists’ perceived that the provision of pharmaceutical care has large benefits to patients’ treatment outcomes [39]. In Jordan (2012), community pharmacists showed positive attitudes toward pharmaceutical care practice by documenting adequate practice [42].

Professional and public health activities

In Jordan (2019), there was poor awareness and practice toward medication reconciliation service in community pharmacies by pharmacists [52]. In Malaysia (2021), interactions between community pharmacists and general practitioners were suboptimal, and more training programs are needed to improve such services [68]. In Turkey (2012), community pharmacists perceived themselves as serving in a clinical consultancy role and advising on drug therapy [65].

Nigerian community pharmacists reported less inclined toward the practice of public health activities due to lack of time, non-cooperative consumers, and shortage of manpower [49]. Compared to Nigeria better results were documented toward public health activities in Yemen as positive attitudes were noticed among community pharmacists, such as providing education about the cessation of smoking and alcohol drinking, good oral hygiene, and measurements of blood pressure and blood glucose level when needed for consumers [48]. In Malaysia (2017), community pharmacists showed positive awareness toward inter/intra-professional activities and pharmaceutical care practice [53]. In UAE (2015), almost all of community pharmacists performed professional practice by contacting physicians to minimize any medications errors and enhance consumers health-related outcomes [54].

Extended pharmacy services for special groups of population

In Malaysia (2020), a practice of lifestyle assistance services was documented to the cardiovascular disease patients among pharmacists in the community setting [58]. In New Zealand (2020), community pharmacists showed positive perceptions toward the provision of Community Pharmacy Anticoagulation Management Service (CPAMS), as it may improve pharmacists–patients relationships, and patients health outcomes [59].

Community pharmacists in the UK (2013) perceived positive attitudes and practice toward pharmaceutical care for patients with dementia. The frequently provided services for patients with dementia were initiation and stopping medications, adherence to medication, and checking the availability of formulation types [55]. In Malaysia (2019), there was positive attitudes toward mental healthcare among community pharmacists, but most mentally ill patients were referred mostly to hospitals for healthcare [56]. Additionally, in Canada (2015), pharmacists showed a positive attitude toward services for patients receiving Anti-Depressant Therapy (ADT), especially for medication initiation [57].

A good range of services for the elderly were perceived to be provided by community pharmacists in New Zealand, such as encouraging medications’ adherence by offering compliance packaging, medication review, and repeat prescription reminders, in addition to some screening services such as blood pressure measurements [60].

In Malaysia (2021), there were low osteoporosis risk assessment tools practice of and modest awareness among community pharmacists [61], while in Lebanon (2019) the perceived back pain management services by community pharmacists were dispensing of non-steroidal anti-inflammatory medications and patients’ referral to the physician when needed [62].

Health promotion activities

Value-added pharmacy services (VAPS) were offered by Bulgarian community pharmacists and mostly common offered service was blood pressure and glucose level measurement, and the community pharmacists perceived positive attitudes toward VAPS [50]. In Malaysia (2019), community pharmacists showed positive perceptions and attitudes toward pharmacist-led minor ailment services [51]. Additionally, in Malaysia (2014), involvement of community pharmacists in health-promotion and health education activities were high, especially in counselling of diabetes, asthma, oral contraceptives, smoking cessation, nutrition and physical activity, and oral health that could enhance public’s health outcomes [47].

The community pharmacists in Nepal (2020), had positive attitudes and practices toward emergency contraception pills [64].

In the USA (2017), positive practice and attitudes were observed among community pharmacists toward vaccinations including influenza vaccine, herpes zoster, pneumococcal polysaccharide (PPSV23), tetanus/diphtheria/pertussis (Tdap), and Human Papillomavirus Vaccination (HPV) [63].

Malaysian community pharmacists showed positive attitudes toward smoking cessation practice, but more continuing education sessions were needed to improve this practice [74]. Compared to Malaysia same results were documented in Jordan (2022), as community pharmacists showed good attitudes toward smoking cessation practice with low practice due to lack of educational materials, minimal demand by consumers, and low training education programs [75].

In Lebanon (2019), positive attitudes were perceived toward oral healthcare services among community pharmacists, but limited interaction with dentists and insufficient training were major concerns of practicing [70]. In Malaysia (2020), frequent oral health consultations were provided by community pharmacists and showed positive attitudes toward provision of oral health services. The most frequent oral healthcare services they provided were over-the-counter (OTC) treatments and referral to dentists [69].

Egyptian community pharmacists perceived positive attitudes toward their role in nutritional assessment and medical nutrition therapy and stated that they routinely provide this service for patients with the following medical conditions; obesity, diabetes and hypertension [77]. In Malaysia (2019), positive attitudes toward weight management services (WMS) observed among community pharmacists as they regularly provided advices to the consumers about physical activity and healthy eating [76].

In Qatar (2013), pharmacists showed positive attitudes toward breast cancer health promotion practice with low level of practice due to lack of educational materials, and public awareness [79]. In Iraq (2017), community pharmacists showed favorable attitudes toward breast cancer health promotion practice but lack of time is the major factor that reduce the level of practicing this service [84]. Similarly, in Jordan (2016), community pharmacists had positive attitudes toward provision of breast cancer health promotion but insufficiency of time and suitable educational skills lower their involvement in this service [80]. In UAE (2013), despite the low participation in breast cancer health promotion practice among community pharmacists, they perceived that providing such services was helpful for females consumers [81]. Additionally, community pharmacists in Palestine (2021), perceived positive attitudes toward breast cancer health promotion, but their concerns toward practice of this service were shortage of staff, insufficiency of time, and fear of offending the patients [82]. Furthermore, in Malaysia (2012) insufficiency of time and lack proper breast cancer educational materials and training were the major causes of not providing breast cancer health promotion by the community pharmacists [83].

Attitudes, awareness, and perceptions of consumers or public toward extended community pharmacy services

In the United Kingdom (2012), the Scottish public showed poor awareness toward healthcare services provided in the community pharmacy setting (13.2%; n = 162). They accepted the idea of consulting community pharmacists regarding weight management services, however the lack of privacy at the community pharmacy setting (47.3%; n = 592) and the perceived lack of pharmacists’ specialist knowledge were the major concerns toward using this service [86]. In Jordan (2018), public showed poor awareness toward the knowledge of pharmaceutical care services at community pharmacy setting (55.1%), they assured the importance of the role of pharmacists in providing healthcare services other than counselling and dispensing and expect much more services to be provided by community pharmacists at their country [87].

Drive-thru community pharmacy services and pharmacists

In Jordan (2017), pharmacists were aware about the concept of drive-thru pharmacy service (n = 194, 85.5%), and the most stated advantage of drive-thru pharmacy service was serving sick customers. Only 27.9% (n = 63) were willing to register with this service. Most of pharmacists believed that drive-thru pharmacy service might affect the image of the pharmacy profession negatively, and make them feel more like a fast food worker than a pharmacist [20].

Drive-thru community pharmacy services and consumers or public

In Jordan (2019), there was a good awareness about drive-thru pharmacy service among the public 26.8% (n = 212). The usage of the service was minimal 10.9% (n = 86), and the most recognized concern among the public while using this service was the poor communication that may happen between the pharmacist and the patient. About 59.1% of the public expressed high support for the introducing this service to the community pharmacy practice [88].

Details of the results are presented in additional files [see Additional file 1].

Discussion

The present systematic review aimed to provide a summary of studies on attitudes, awareness, or perceptions toward various extended and drive-thru pharmacy services at community settings among pharmacists and the public.

In this review, it is noted that there is a positive shift toward patients’ health outcomes services at community pharmacy setting. This shift is very helpful for patient healthcare outcomes and may improve the interactions between all healthcare providers [92]. Contacting physicians by community pharmacists to minimize medications errors and improve health-related outcomes was noted in UAE [54]. The awareness toward interaction between community pharmacists and general practitioners (GPs) was noted in Malaysia, but the practice of such service was suboptimal [68]. To solve this malpractice, teaching programs at universities for undergraduates will improve the interactions between pharmacists and GPs [93].

Positive attitudes were noted among community pharmacists toward public health activities such as providing education about some health conditions, measurements of blood pressure and blood glucose level at community pharmacy [48]. Additionally, a good practice was noted in Malaysia among community pharmacists toward health education activities for some health conditions such as diabetes education, asthma education, oral health education, and others that could play an important role in enhancing public’s health outcomes [47]. However, there were poor attitudes toward public health activities among community pharmacists in Nigeria due to some factors such as lack of time, non-cooperative consumers, and shortage of manpower [49]. These factors could be improved through enhanced awareness of public toward such service, and increasing community pharmacists’ incentives [49, 94].

Studies in this review, also have shown positive attitudes toward pharmaceutical care among community pharmacists in Nigeria, Malaysia, Jamaica, Poland, China, Iran, Jordan, and Pakistan [35,36,37,38, 40,41,42, 44, 95]. However, it is noted that some factors prevent community pharmacists provide pharmaceutical care all the time. For example, it is observed that lack of time or staff or resources shortages are the main barriers to its practice in Nigeria, Jamaica, Poland, and Pakistan [35, 36, 38, 41]. Professional skills to shift pharmacists’ traditional roles into extended roles are essential [96].

In this review, positive attitudes and perceptions were noted toward various EPS that are related to a special group of populations such as services for geriatrics, services for mental disorders, cardiovascular risk assessment, osteoporosis risk assessment, dermatologic care services, cancer health promotion, and infectious care services such as vaccinations, and travel medicine service [55,56,57, 60, 61, 63, 71, 73, 79,80,81, 84, 85, 97]. These specialized extended pharmaceutical services can be promoted by various specialized training courses of the Board of Pharmacy Specialties (BPS), such as geriatrics, psychiatric, cardiology, pharmacotherapy, oncology, and infectious [98].

It was noted that there is a lack of educational courses, and training programs for pharmacists, to practice smoking cessation services confidently [74, 75]. Healthcare providers who have received training programs for smoking cessation services will practice such services more than those who did not [99]. Other training programs that listed under continuous pharmacy education, such as anticoagulation program, prepare pharmacists to practice these extended pharmacy services smoothly and enhance patients’ health outcomes [100]. Comparable findings were noted in New Zealand; by application of The Community Pharmacy Anticoagulation Management Service (CPAMS), better anticoagulation control were noticed and community pharmacists who were involved in CAMPS showed positive attitudes toward it [59, 101].

Furthermore, it is noted that public had positive attitudes and perceptions toward EPS which are accessible and helpful for them. However, poor awareness toward EPS and some concerns toward its provision by community pharmacists where highlighted by public such as the lack of pharmacists’ specialized skills for providing EPS [86, 87]. Therefore, it is important to improve pharmacists’ skills to provide such extended services through training programs. Findings toward perceptions of various EPS practices among pharmacists and the public were positive, but more training and experienced skills are needed to provide such services and promote pharmacy practice. Comparable findings were noted in a previous systematic review of EPS as positive perspectives were observed with noted barriers that inhibit such performance, and more training programs are needed to improve EPS practice [102].

A good awareness was noted toward drive-thru service at community setting among pharmacists and public [20, 88]. However, some concerns were noted while using this service, such as the poor communication between the pharmacist and the patient; this can be intervened by applying telemedicine [103], and developing of standard drive-thru model to facilitate its application efficiently [23].

Limitations

This study is not devoid of limitations. We limited our review retrieval to Embase, Medline PubMed, Scopus, Web of Science, and Science Direct search engines, English language published studies, and studies that published between March/2012 and March/2022. Although we have done cross-referencing, which added a few studies in our review, we still cannot claim that we had access to all the relevant articles related to this topic. Several limitations were noted in the included studies. For instance, most cross-sectional studies utilized a self-administered questionnaire to assess perceptions and awareness, so results are prone to measurement bias.

Conclusion

Most included studies showed good awareness or perceptions toward EPS and drive-thru pharmacy service in community settings among pharmacists or the public. These services are beneficial for health-related outcomes. Ultimately, understanding the major concerns toward providing these services and improving pharmacists’ skills through more training programs to provide such services efficiently. In the future, more reviews for EPS practice concerns are recommended, to solve those concerns and find standardized guidelines by stakeholders and organizations for efficient EPS practices.

Availability of data and materials

All data generated or analyzed during this study are included in this published article (and its additional files).

Abbreviations

EPS:

Extended Pharmacy Services

UK:

United Kingdom

UAE:

United Arab Emirates

PRISMA:

Preferred Reporting Items for Systematic Reviews and Meta-Analysis

MESH:

Medical Subject Headings

NIH:

National Institute of Health

JBI:

Joanna Briggs Institute

MAAT:

Mixed Methods Appraisal Tool

SWiM:

A Synthesis Without Meta-Analysis

HPV:

Human Papillomavirus Vaccination

PPSV23:

Pneumococcal polysaccharide

Tdap:

Tetanus/diphtheria/pertussis

OTC:

Over the counter

GPs:

General Practitioners

ADT:

Anti-depressant therapy

CPAMS:

Community Pharmacy Anticoagulation Management Service

VAPS:

Value-Added Pharmacy Services

BPS:

Board of Pharmacy Specialties

WMS:

Weight Management Services

References

  1. Goel PK, Ross-Degnan D, Berman P, Soumerai S. Retail pharmacies in developing countries: a behavior and intervention framework. Soc Sci Med. 1996;42(8):1155–61.

    Article  CAS  PubMed  Google Scholar 

  2. Hepler CD. Pharmaceutical care and specialty practice. Pharmacother J Hum Pharmacol Drug Ther. 1993;13(2P2):64S-69S.

    CAS  Google Scholar 

  3. Berbatis CG, Sunderland VB, Joyce A, Bulsara M, Mills C. Enhanced pharmacy services, barriers and facilitators in Australia’s community pharmacies: Australia’s National Pharmacy Database Project. Int J Pharm Pract. 2010;15(3):185–91.

    Article  Google Scholar 

  4. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47(3):533–43.

    CAS  PubMed  Google Scholar 

  5. Farris KB, Fernandez-Llimos F, Benrimoj SI. Pharmaceutical care in community pharmacies: practice and research from around the world. Ann Pharmacother. 2005;39(9):1539–41.

    Article  PubMed  Google Scholar 

  6. Abramowitz PW. The evolution and metamorphosis of the pharmacy practice model. Am J Health Syst Pharm. 2009;66(16):1437–46.

    Article  PubMed  Google Scholar 

  7. Miller S, Patel N, Vadala T, Abrons J, Cerulli J. Defining the pharmacist role in the pandemic outbreak of novel H1N1 influenza. J Am Pharm Assoc. 2012;52(6):763.

    Article  Google Scholar 

  8. Schwerzmann J, Graitcer SB, Jester B, Krahl D, Jernigan D, Bridges CB, et al. Evaluating the impact of pharmacies on pandemic influenza vaccine administration. Disaster Med Public Health Prep. 2017;11(5):587.

    Article  PubMed  Google Scholar 

  9. Jones EJM, MacKinnon NJ, Tsuyuki RT. Pharmaceutical care in community pharmacies: practice and research in Canada. Ann Pharmacother. 2005;39(9):1527–33.

    Article  PubMed  Google Scholar 

  10. Saramunee K, Krska J, Mackridge A, Richards J, Suttajit S, Phillips-Howard P. How to enhance public health service utilization in community pharmacy? General public and health providers’ perspectives. Res Soc Adm Pharm. 2014;10(2):272–84.

    Article  Google Scholar 

  11. Brown D, Portlock J, Rutter P, Nazar Z. From community pharmacy to healthy living pharmacy: positive early experiences from Portsmouth, England. Res Soc Adm Pharm. 2014;10(1):72–87.

    Article  Google Scholar 

  12. Gilbert L. Pharmacist and nurse: a team approach towards primary health care or a convenient “therapeutic alliance”? Int J Nurs Stud. 1997;34(5):367–74.

    Article  CAS  PubMed  Google Scholar 

  13. Moullin JC, Sabater-Hernández D, Fernandez-Llimos F, Benrimoj SI. Defining professional pharmacy services in community pharmacy. Res Soc Adm Pharm. 2013;9(6):989–95.

    Article  Google Scholar 

  14. A. M. Drive-through Businesses. American Business History and Civil Liberties. 2011.

  15. Boots opens Britain’s first drive-through chemist... in an old McDonald’s. Daily mail online. https://www.dailymail.co.uk/health/article-1047196/Boots-opens-Britains-drive-chemist--old-McDonalds.html. Accessed 5 Oct 2022.

  16. Drive Thru Pharmacy Griffith Soul Pattinson Chemist. Drive Thru Pharmacy Griffith. https://www.drivethrupharmacy.com.au/. Accessed 5 Oct 2022.

  17. First drive-through pharmacy opens in Zagreb—the Dubrovnik times. https://www.thedubrovniktimes.com/news/croatia/item/1879-first-drive-through-pharmacy-opens-in-zagreb. Accessed 5 Oct 2022.

  18. Lin YF, Lin YM, Sheng LH, Chien HY, Chang TJ, Zheng CM, et al. First drive-through pharmacy services in Taiwan. J Chin Med Assoc. 2013;76(1):37–41.

    Article  PubMed  Google Scholar 

  19. Sulaiman SB. Customer’s satisfaction on the Implementation of drive-through pharmacy in Penang General Hospital, Penang, Malaysia—pilot study. Conference: first regional health sciences and nursing. 2022. https://www.researchgate.net/publication/267512407_Customer’s_satisfaction_on_the_Implementation_of_Drive-Through_Pharmacy_in_Penang_General_Hospital_Penang_Malaysia_-_Pilot_Study. Accessed 21 Sept 2022.

  20. Abu Farha R, Abu Hammour K, Alefishat E, Alsaeed H, Alma’aiah S. Drive-thru pharmacy service: assessments of awareness, perception and barriers among pharmacists in Jordan. Saudi Pharm J. 2017;25(8):1231–6.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Diri RM. The impact of COVID-19 outbreak on reassessing the need for drive thru community pharmacy: cross-sectional study. J Microsc Ultrastruct. 2020;8(4):162–4.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Sidra Medicine introduces drive-through pharmacy. The Peninsula Qatar. https://thepeninsulaqatar.com/article/25/03/2020/Sidra-Medicine-introduces-drive-through-pharmacy. Accessed 26 Sept 2022.

  23. Hussain R, Dawoud DM, Babar ZUD. Drive-thru pharmacy services: a way forward to combat COVID-19 pandemic. Res Social Adm Pharm. 2021;17(1):1920–4.

    Article  PubMed  Google Scholar 

  24. Christensen DB, Penna PM. Quality assessment and quality assurance of pharmacy services. J Manag Care Pharm. 1995;1(1):40–51.

    Google Scholar 

  25. Boudreaux ED, O’Hea EL. Patient satisfaction in the emergency department: a review of the literature and implications for practice. J Emerg Med. 2004;26(1):13–26.

    Article  PubMed  Google Scholar 

  26. Saiboon I, Siew Eng H, Krishnan B, Nooraini Ali S, Murad N, Pathnathan A, et al. A study of patients’ satisfaction with the emergency department (ED) of hospital Universiti Kebangsaan Malaysia (HUKM). Med Health. 2008;3(1):7–13.

    Google Scholar 

  27. White L, Klinner C. Service quality in community pharmacy: an exploration of determinants. Res Social Adm Pharm. 2012;8(2):122–32.

    Article  PubMed  Google Scholar 

  28. Zeithaml VA, Berry LL, Parasuraman A. Communication and control processes in the delivery of service quality. J Mark. 1988;52(2):35.

    Article  Google Scholar 

  29. Jeffrey Pickens. (17) (PDF) attitudes and perceptions. 2005 https://www.researchgate.net/publication/267362543_Attitudes_and_Perceptions. Accessed 10 Jan 2023.

  30. AWARENESS. English meaning—Cambridge dictionary. https://dictionary.cambridge.org/dictionary/english/awareness. Accessed 10 Jan 2023.

  31. Study quality assessment tools. NHLBI, NIH. https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools. Accessed 4 Aug 2022.

  32. Critical appraisal tools. JBI. https://jbi.global/critical-appraisal-tools. Accessed 8 Sept 2022.

  33. Nha HONG Q, Pluye P, Fàbregues S, Bartlett G, Boardman F, Cargo M, et al. Mixed methods appraisal tool (MMAT) Version 2018 User guide. 2022. http://mixedmethodsappraisaltoolpublic.pbworks.com/. Accessed 8 Sept 2022.

  34. Campbell M, McKenzie JE, Sowden A, Katikireddi SV, Brennan SE, Ellis S, et al. Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline. BMJ. 2020. https://doi.org/10.1136/bmj.l6890.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Hashmi FK, Hassali MA, Khalid A, Saleem F, Aljadhey H, Babar ZUD, et al. A qualitative study exploring perceptions and attitudes of community pharmacists about extended pharmacy services in Lahore, Pakistan. BMC Health Serv Res. 2017;17(1):500.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Amibor KC, Okonta C. Attitude and practice of community pharmacists towards pharmaceutical care in Nigeria. J Drug Deliv Ther. 2019;9(6-s):164–71.

    Article  Google Scholar 

  37. Oi C, Ung L, Chao CK, Hu Y, Zhao J, Li P, et al. Community pharmacists ’ understanding, attitudes, practice and perceived barriers related to providing pharmaceutical care : a questionnaire-based survey in Macao. Trop J Pharm Res. 2016;15(4):847–54.

    Article  Google Scholar 

  38. Kopciuch D, Paczkowska A, Zaprutko T, Ratajczak P, Kus K. A survey of pharmacists’ knowledge, attitudes and barriers in pharmaceutical care concept in Poland. BMC Med Educ. 2021;21(1):1.

    Article  Google Scholar 

  39. Mehralian G, Rangchian M, Afsharmanesh G, Seifi N. Pharmaceutical care in a community-based practice setting in Iran: current status and future challenges. J Pharm Heal Serv Res. 2015;6(1):69–75.

    Google Scholar 

  40. Maaji H, Suberu O. Assessment of knowledge, attitude and practice of community pharmacist towards pharmaceutical care. Int J Pharm Teach Pract. 2014;5:972–6.

    Google Scholar 

  41. Evans RMV, Bromfield LE, Brown PG. An investigation of knowledge, attitude, and practice of community pharmacists toward pharmaceutical care in private community pharmacies in Jamaica. Trop J Pharm Res. 2021;20(12):2587–95.

    Google Scholar 

  42. Aburuz S, Al-Ghazawi M, Snyder A. Pharmaceutical care in a community-based practice setting in Jordan: where are we now with our attitudes and perceived barriers? Int J Pharm Pract. 2012;20(2):71–9.

    Article  PubMed  Google Scholar 

  43. Kharaba Z, Kousar R, Azhar S, Buabeid MA, Khan SA, Murtaza G. Exploring community pharmacists perception towards responsible provision of patient care services: a quantitative assessment. Trop J Pharm Res. 2020;19(4):879–85.

    Article  Google Scholar 

  44. Alakhali KM, Khadari MZ, Rajagopal M, Baig A, Helweh O. Attitude towards professional practice among community pharmacists’ in Kuala Lumpur, Malaysia. Ars Pharm. 2021;62(2):118–30.

    Article  Google Scholar 

  45. Song M, Ung COL, Hu H, Wang Y. Community pharmacists’ perceptions about pharmaceutical care of OTC western medicine: a survey in Harbin of China. Int J Clin Pharm. 2015;37(6):1014–20.

    Article  PubMed  Google Scholar 

  46. Song M, Ung COL, Lee VW-Y, Hu Y, Zhao J, Li P, et al. Community pharmacists’ perceptions about pharmaceutical service of over-the-counter traditional Chinese medicine: a survey study in Harbin of China. BMC Complement Altern Med. 2017;17(1):9.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Beshir SA, Bt Hamzah NH. Health promotion and health education: Perception, barriers and standard of practices of community pharmacists. Int J Health Promot Educ. 2014;52(4):174–80.

    Article  Google Scholar 

  48. Yousuf SA, Alshakka M, Badulla WFS, Ali HS, Shankar PR, Mohamed Ibrahim MI. Attitudes and practices of community pharmacists and barriers to their participation in public health activities in Yemen: mind the gap. BMC Health Serv Res. 2019;19(1):304.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Offu O, Anetoh M, Okonta M, Ekwunife O. Engaging Nigerian community pharmacists in public health programs: assessment of their knowledge, attitude and practice in Enugu metropolis. J Pharm Policy Pract. 2015;8(1):1–7.

    Article  Google Scholar 

  50. Balkanski S, Simeonova J, Gitev I, Getov I. Evaluation of the current status of the value-added pharmacy services and pharmacists’ attitude in Bulgaria. Pharmacia. 2019;66(2):79–83.

    Article  CAS  Google Scholar 

  51. Selvaraj A, Redzuan AM, Hatah E. Community pharmacists’ perceptions, attitudes and barriers towards pharmacist-led minor ailment services in Malaysia. Int J Clin Pharm. 2020;42(2):777–85.

    Article  PubMed  Google Scholar 

  52. Farha RA, Hammour KA, Mukattash T, Alqudah R, Aljanabi R. Medication histories documentation at the community pharmacy setting: a study from Jordan. PLoS ONE. 2019;14(10): e0224124.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Ali AN, Shalini S, Yen PN, Yee RS, Jia YS, et al. Community pharmacists attitude towards professional practice in Penang, Malaysia. J Pharm Pract Community Med. 2017;3(4):232–9.

    Article  Google Scholar 

  54. Rayes IK, Hassali MA, Abduelkarem AR. Perception of community pharmacists toward their current professional role in the healthcare system of Dubai, United Arab Emirates. Saudi Pharm J. 2015;23(3):235–40.

    Article  PubMed  Google Scholar 

  55. Barry HE, Parsons C, Passmore AP, Hughes CM. Community pharmacists and people with dementia: a cross-sectional survey exploring experiences, attitudes, and knowledge of pain and its management. Int J Geriatr Psychiatry. 2013;28(10):1077–85.

    Article  PubMed  Google Scholar 

  56. Wong YX, Khan TM, Wong ZJ, Ab Rahman AF, Jacob SA. Perception of community pharmacists in Malaysia about mental healthcare and barriers to providing pharmaceutical care services to patients with mental disorders. Community Ment Health J. 2020;56(1):88–98. https://doi.org/10.1007/s10597-019-00496-4.

    Article  PubMed  Google Scholar 

  57. Guillaumie L, Moisan J, Grégoire JP, Villeneuve D, Beaucage C, Bujold M, et al. Perspective of community pharmacists on their practice with patients who have an antidepressant drug treatment: findings from a focus group study. Res Social Adm Pharm. 2015;11(2):e43-56.

    Article  PubMed  Google Scholar 

  58. Sia HP, Khan TM, Redzuan AM. Community pharmacists’ perception and experience in providing lifestyle assistance to patients with cardiovascular disease. Int J Pharm Sci Res. 2020;11(9):4338–48. https://doi.org/10.13040/IJPSR.0975-8232.

    Article  Google Scholar 

  59. Beyene K, Chan AHY, Barton E, Yan S, Singh S, Basani A, et al. Pharmacists views on participating in New Zealand’s community pharmacy anticoagulation management service: a mixed-methods study. Int J Clin Pharm. 2021;43(1):251–62. https://doi.org/10.1007/s11096-020-01148-4.

    Article  PubMed  Google Scholar 

  60. Tordoff J, Chang SY, Norris PT. Community pharmacists’ perceptions of services that benefit older people in New Zealand. Int J Clin Pharm. 2012;34(2):342–50.

    Article  PubMed  Google Scholar 

  61. Francis J, Toh LS, Sellappans R, Loo JSE. Awareness of osteoporosis risk assessment tools and screening recommendations among community pharmacists in Malaysia. Int J Clin Pharm. 2021;43(3):604–12. https://doi.org/10.1007/s11096-020-01169-z.

    Article  PubMed  Google Scholar 

  62. Dabbous MK, Moustafa SM, Sakr FR, AKel MG, Safwan JH, Cherfan MM, et al. Knowledge, attitude and practice of Lebanese community pharmacists with regard to self-management of low back pain. Trop J Pharm Res. 2020;19(4):873.

    Article  Google Scholar 

  63. Hastings T, Hohmann L, McFarland S, Teeter B, Westrick S. Pharmacists’ attitudes and perceived barriers to human papillomavirus (HPV) vaccination services. Pharmacy. 2017;5(4):45.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Shakya S, Shrestha S, Shrestha RK, Giri U, Shrestha S. Knowledge, attitude and practice of emergency contraceptive pills among community pharmacy practitioners working in Kathmandu Valley: a cross-sectional study. BMC Health Serv Res. 2020;20(1):1.

    Article  Google Scholar 

  65. Erdogan ON, Erdogan MS, Gunay ON, Erkus S, Ulus T. Community pharmacists’ perception of their clinical pharmacy service function, a study from Turkey. Farmacia. 2012;60(5):749–58.

    Google Scholar 

  66. Millar AN, Hughes CM, Ryan C. A qualitative study of community pharmacists’ awareness of and involvement with intermediate care facilities. Eur J Pers Cent Healthc. 2016;4(1):53.

    Google Scholar 

  67. Millar A, Hughes C, Devlin M, Ryan C. A cross-sectional evaluation of community pharmacists’ perceptions of intermediate care and medicines management across the healthcare interface. Int J Clin Pharm. 2016;38(6):1380–9.

    Article  PubMed  PubMed Central  Google Scholar 

  68. Alabid AHMA, Ibrahim MIM, Hassali MA, Palaian S. Community pharmacists’ awareness toward their roles in healthcare and interaction with general practitioners: a cross-sectional study. J Pharm Bioallied Sci. 2021;13(2):220–9.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Blebil A, Dujaili J, Elkalmi R, Tan HLK, Tai MS, Khan TM. Community pharmacist’s role in providing oral health-care services: findings from Malaysia. J Pharm Bioallied Sci. 2020;12(1):64–71.

    Article  PubMed  PubMed Central  Google Scholar 

  70. Hajj A, Hallit S, Azzo C, Abdou F, Akel M, Sacre H, et al. Assessment of knowledge, attitude and practice among community pharmacists towards dental care: a national cross sectional survey. Saudi Pharm J. 2019;27(4):475–83.

    Article  PubMed  PubMed Central  Google Scholar 

  71. Thandar Y, Botha J, Mosam A. Community pharmacists’ knowledge, attitude and practices towards the use of complementary and alternative medicines in Durban, South Africa. Health SA Gesondheid. 2019;24:1–6.

    Article  Google Scholar 

  72. Ghanem RE, Mostafa SH, Abu Hamamda NK, Khdour MR. Knowledge, attitudes, and practices of community pharmacists toward the management of acne vulgaris in Palestine: a cross-sectional study. Int J Dermatol. 2020;59(4):506–12.

    Article  PubMed  Google Scholar 

  73. Taha NA, See YL. Provision of travel medicine advice through community pharmacies: assessment of knowledge, attitudes and practices of pharmacists in Malaysia (IJPP-15–0064.R2). Int J Pharm Pract. 2016. https://doi.org/10.1111/ijpp.12256.

    Article  PubMed  Google Scholar 

  74. Taha NA, Tee OG. Tobacco cessation through community pharmacies: knowledge, attitudes, practices and perceived barriers among pharmacists in Penang. Health Educ J. 2015;74(6):681–90.

    Article  Google Scholar 

  75. Sakka S, Al-Shatanawi TN, Bataineh DZ, Haddad W, Al Tamimi S, Al Salamat H, et al. Knowledge, attitude, practice and perceived barriers towards smoking cessation services among community pharmacists. Pharm Pract. 2022;20(1):2637.

    Google Scholar 

  76. Verma RK, Paraidathathu T, Taha NA, Chong WW. Attitudes, practices, and barriers of Malaysian community pharmacists toward provision of weight management services. Front Pharmacol. 2019;10:138.

    Article  PubMed  PubMed Central  Google Scholar 

  77. Medhat M, Sabry N, Ashoush N. Knowledge, attitude and practice of community pharmacists towards nutrition counseling. Int J Clin Pharm. 2020;42(6):1456–68.

    Article  CAS  PubMed  Google Scholar 

  78. Mensah KB, Oosthuizen F, Bangalee V. Cancer health promotion in Ghana: a survey of community pharmacists’ perception and barriers. J Oncol Pharm Pract. 2020;26(6):1361–8.

    Article  PubMed  Google Scholar 

  79. El Hajj MS, Hamid Y. Breast cancer health promotion in Qatar: a survey of community pharmacists’ interests and needs. Int J Clin Pharm. 2013;35(3):376–85.

    Article  PubMed  Google Scholar 

  80. Ayoub NM, Nuseir KQ, Othman AK, Abu AS. Knowledge, attitudes and barriers towards breast cancer health education among community pharmacists. J Pharm Health Serv Res. 2016;7(3):189–98.

    Article  Google Scholar 

  81. Ibrahim OHM, Ibrahim RM. Community pharmacists’ involvement in breast cancer health promotion in United Arab Emirates (UAE). Am J Pharmacol Toxicol. 2013;8(4):155–63. https://doi.org/10.3844/ajptsp.2013.155.163.

    Article  Google Scholar 

  82. Shawahna R, Awawdeh H. Pharmacists’ knowledge, attitudes, beliefs, and barriers toward breast cancer health promotion: a cross-sectional study in the Palestinian territories. BMC Health Serv Res. 2021;21(1):429.

    Article  PubMed  PubMed Central  Google Scholar 

  83. Beshir SA, Hanipah MA. Knowledge, perception, practice and barriers of breast cancer health promotion activities among community pharmacists in two districts of Selangor state, Malaysia. Asian Pac J Cancer Prev. 2012;13(9):4427–30.

    Article  PubMed  Google Scholar 

  84. Ayoub NM, Nuseir KQ, Othman AK, Abu Alkishik S. Knowledge, attitudes and barriers towards breast cancer health education among Iraqi community pharmacists. J Pharm Health Serv Res. 2017. https://doi.org/10.1111/jphs.12140.

    Article  Google Scholar 

  85. Sendall MC, Ostermann L, Brown C, McCosker L, et al. Health promotion of bowel cancer and breast cancer screening in community pharmacies: pharmacists’ perceptions of their role, knowledge and confidence. Pharm Pract. 2018;16(4):1275.

    Google Scholar 

  86. Weidmann AE, Cunningham S, Gray G, Hansford D, Bermano G, Stewart D. Views of the Scottish general public on community pharmacy weight management services: international implications. Int J Clin Pharm. 2012;34(2):389–97.

    Article  PubMed  Google Scholar 

  87. Mukattash TL, Bazzi NH, Nuseir KQ, Jarab AS, Abu-Farha RK, Khdour MR, et al. Pharmaceutical care in community pharmacies in Jordan: a public survey. Pharm Pract. 2018;16(2):1126.

    Google Scholar 

  88. Abu Hammour K, Abu Farha R, Rizik M, Mukattash T, Alnan M, Alkhader A, et al. Pharmacy drive-thru service in Jordan: assessing customers’ awareness, perceptions and factors affecting the use of this service. J Pharm Heal Serv Res. 2019;10(1):141.

    Article  Google Scholar 

  89. Turner S, Botero-Tovar N, Herrera MA, Borda Kuhlmann JP, Ortiz F, Ramírez JC, et al. Systematic review of experiences and perceptions of key actors and organisations at multiple levels within health systems internationally in responding to COVID-19. Implement Sci. 2021;16(1):1–13.

    Article  Google Scholar 

  90. Rojas-García A, Turner S, Pizzo E, Hudson E, Thomas J, Raine R. Impact and experiences of delayed discharge: a mixed-studies systematic review. Health Expect. 2018;21(1):41–56.

    Article  PubMed  Google Scholar 

  91. Turner S, D’Lima D, Hudson E, Morris S, Sheringham J, Swart N, et al. Evidence use in decision-making on introducing innovations: a systematic scoping review with stakeholder feedback. Implement Sci. 2017;12(1):145.

    Article  PubMed  PubMed Central  Google Scholar 

  92. Goode J-V, Owen J, Page A, Gatewood S. Community-based pharmacy practice innovation and the role of the community-based pharmacist practitioner in the United States. Pharmacy. 2019;7(3):106.

    Article  PubMed  PubMed Central  Google Scholar 

  93. Bugnon O, Hugentobler-Hampaï D, Berger J, Schneider MP. New roles for community pharmacists in modern health care systems: a challenge for pharmacy education and research. Chimia (Aarau). 2012;66(5):304–7.

    Article  CAS  PubMed  Google Scholar 

  94. Eades CE, Ferguson JS, O’Carroll RE. Public health in community pharmacy: a systematic review of pharmacist and consumer views. BMC Public Health. 2011;11:582.

    Article  PubMed  PubMed Central  Google Scholar 

  95. Mehralian G, Yousefi N, Hashemian F, Maleksabet H. Knowledge, attitude and practice of pharmacists regarding dietary supplements : a community pharmacy-based survey in Tehran. Iran J Pharm Res. 2014;13(4):1457–65.

    PubMed  PubMed Central  Google Scholar 

  96. Shakeel S, Iffat W, Riffat Y, Huma A, Sadaf I. Pharmacy student ’ s perception and attitude towards the course and scope of community pharmacy in Pakistan. J Pharm Biomed Sci. 2016;32(32):1400–6.

    Google Scholar 

  97. Sia HP, Khan TM, Redzuan AM. Community pharmacists’ perception and experience in providing lifestyle assistance to patients with cardiovascular disease. Int J Pharm Sci Res. 2020;11(9):4338–48.

    Google Scholar 

  98. BPS specialties—board of pharmacy specialties. https://www.bpsweb.org/bps-specialties/. Accessed 7 Sept 2022.

  99. Carson KV, Verbiest MEA, Crone MR, Brinn MP, Esterman AJ, Assendelft WJJ, et al. Training health professionals in smoking cessation. Cochrane Database Syst Rev. 2012. https://doi.org/10.1002/14651858.CD000214.pub2/full.

    Article  PubMed  PubMed Central  Google Scholar 

  100. Anticoagulation therapy management for pharmacists. Continuing pharmacy education, college of pharmacy, University of Florida. https://cpe.pharmacy.ufl.edu/2020/12/30/anticoagulation-therapy-management-for-pharmacists/. Accessed 7 Sept 2022.

  101. Harrison J, Shaw JP, Harrison JE. Anticoagulation management by community pharmacists in New Zealand: an evaluation of a collaborative model in primary care. Int J Pharm Pract. 2015;23(3):173–81.

    Article  PubMed  Google Scholar 

  102. Nordin N, Hassali MAA, Sarriff A. A global picture of extended pharmacy services, perceptions, and barriers toward its performance: a systematic review. Asian J Pharm Clin Res. 2017;10(11):417–27.

    Article  Google Scholar 

  103. Babar ZUD, Scahill S, Nagaria RA, Curley LE. The future of pharmacy practice research—perspectives of academics and practitioners from Australia, NZ, United Kingdom, Canada and USA. Res Social Adm Pharm. 2018;14(12):1163–71.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

  1. Discipline of Social and Administrative Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia

    Bayan F. Ababneh, Siew Chin Ong & Rabia Hussain

  2. Discipline of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, Scotland, UK

    Fatema Mahmoud

  3. Discipline of Clinical Pharmacy, Faculty of Pharmacy, Near East University, Nicosia, Northern Cyprus, Turkey

    Louai Alsaloumi

Authors
  1. Bayan F. Ababneh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Siew Chin Ong
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Fatema Mahmoud
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Louai Alsaloumi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Rabia Hussain
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

BFA, SCO, and RH contributed to the conception and design of the study. BFA imported the search results from all databases. BFA, FM, and LA managed the studies selection process from the title and abstract screening to full-text screening. BFA, FM, and LA managed the data extraction phase. BFA and FM contributed to the quality assessment process. BFA, SCO, and RH reviewed the final draft and proofread the article. All authors stated that they had complete access to the study data that support the publication. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Siew Chin Ong.

Ethics declarations

Ethics approval and consent to participate

This systematic review was designed according to the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) statement and was registered in the Prospero database (CRD42022314516). Ethical approval was not required as our study did not include confidential participant data and interventions.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1.

Characteristics of the included studies in the review.

Additional file 2.

Quality assessment details of included studies in this systematic review.

Additional file 3.

Quality assessment grading of included studies in this systematic review.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ababneh, B.F., Ong, S.C., Mahmoud, F. et al. Attitudes, awareness, and perceptions of general public and pharmacists toward the extended community pharmacy services and drive-thru pharmacy services: a systematic review. J of Pharm Policy and Pract 16, 37 (2023). https://doi.org/10.1186/s40545-023-00525-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s40545-023-00525-4

Keywords

Journal of Pharmaceutical Policy and Practice

ISSN: 2052-3211

Contact us